K Farrag

680 total citations
20 papers, 446 citations indexed

About

K Farrag is a scholar working on Hematology, Genetics and Nutrition and Dietetics. According to data from OpenAlex, K Farrag has authored 20 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 6 papers in Genetics and 6 papers in Nutrition and Dietetics. Recurrent topics in K Farrag's work include Iron Metabolism and Disorders (10 papers), Hemoglobinopathies and Related Disorders (6 papers) and Erythropoietin and Anemia Treatment (5 papers). K Farrag is often cited by papers focused on Iron Metabolism and Disorders (10 papers), Hemoglobinopathies and Related Disorders (6 papers) and Erythropoietin and Anemia Treatment (5 papers). K Farrag collaborates with scholars based in Germany, Türkiye and Netherlands. K Farrag's co-authors include Jürgen M. Stein, Axel Dignaß, A Aksan, Oliver C. Schroeder, E. R. Brunt, Udo Rüb, Helmut Heinsen, Horst‐Werner Korf, Wilfred F.A. den Dunnen and Heinfried H. Radeke and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMJ and Frontiers in Immunology.

In The Last Decade

K Farrag

20 papers receiving 442 citations

Peers

K Farrag

HEMAT

GENET

Manuela Balocco Italy

Anwar Al‐Awadhi Kuwait

Catherine E. Correia United States

Sibel Oğuzkan Balcı Türkiye

Mai Ohsawa Japan

Farhad Sahebjam United States

Rachel H. Bonami United States

Shouping Gong China

Elizabeth Lee United States

Charalampos Tsentidis Greece

Manuela Balocco Italy

K Farrag

262 ×1.2

HEMAT

270 ×2.1

GENET

139 ×1.7

72 ×0.9

6 ×0.1

GENET

Citations per year, relative to K Farrag K Farrag (= 1×) peers Manuela Balocco

Countries citing papers authored by K Farrag

Since Specialization

Citations

This map shows the geographic impact of K Farrag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Farrag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Farrag more than expected).

Fields of papers citing papers by K Farrag

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Farrag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Farrag. The network helps show where K Farrag may publish in the future.

Co-authorship network of co-authors of K Farrag

This figure shows the co-authorship network connecting the top 25 collaborators of K Farrag. A scholar is included among the top collaborators of K Farrag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Farrag. K Farrag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lande, Roberto, Alica Kubesch, K Farrag, et al.. (2024). P046 Real-world data on the treatment with Mirikizumab in a mostly biological-experienced Ulcerative colitis cohort. Journal of Crohn s and Colitis. 18(Supplement_1). i304–i304. 2 indexed citations

Farrag, K, et al.. (2024). Use of Biomarkers of Inflammation in the Differentiation of Iron Deficiency and Anaemia—Lessons from Inflammatory Bowel Disease. Diagnostics. 14(14). 1515–1515. 4 indexed citations

Farrag, K, et al.. (2022). P642 Crossroads of vitamin B6 deficiency and inflammation in inflammatory bowel disease: Preliminary results of a cross-sectional study. Journal of Crohn s and Colitis. 16(Supplement_1). i558–i559. 1 indexed citations

Aksan, A, et al.. (2021). Flipside of the Coin: Iron Deficiency and Colorectal Cancer. Frontiers in Immunology. 12. 635899–635899. 47 indexed citations

Aksan, A, K Farrag, Irina Blumenstein, et al.. (2021). Chronic intestinal failure and short bowel syndrome in Crohn’s disease. World Journal of Gastroenterology. 27(24). 3440–3465. 25 indexed citations

Farrag, K. (2021). Diagnostic utility of low hemoglobin density to detect iron deficiency in patients with inflammatory bowel disease. Annals of Gastroenterology. 34(4). 521–527. 2 indexed citations

Aksan, A, et al.. (2021). Zinc Protoporphyrin Is a Reliable Marker of Functional Iron Deficiency in Patients with Inflammatory Bowel Disease. Diagnostics. 11(2). 366–366. 5 indexed citations

Farrag, K, A Aksan, Oliver Schröder, & Jürgen M. Stein. (2020). Orale Eisensubstitution (therapie?) bei CED - weniger ist meist mehr?. Zeitschrift für Gastroenterologie. 1 indexed citations

Stier, Christine, et al.. (2019). Is Early Reimplantation of the Duodenal–Jejunal Bypass Liner Viable?. Obesity Surgery. 29(5). 1690–1693. 6 indexed citations

10.

Farrag, K, Yogesh M. Shastri, Ulrike Beilenhoff, A Aksan, & Jürgen M. Stein. (2019). Percutaneous endoscopic gastrostomy (PEG): a practical approach for long term management. BMJ. 364. k5311–k5311. 12 indexed citations

11.

Kubesch, Alica, K Farrag, Thomas Krause, et al.. (2019). Short and Long-Term Effectiveness of Ustekinumab in Patients with Crohn’s Disease: Real-World Data from a German IBD Cohort. Journal of Clinical Medicine. 8(12). 2140–2140. 35 indexed citations

12.

Aksan, A, Hatice Işık, K Farrag, Axel Dignaß, & Jürgen M. Stein. (2019). P701 The comparative safety of different intravenous iron preparations in inflammatory bowel disease: a systematic review and network meta-analysis. Journal of Crohn s and Colitis. 13(Supplement_1). S471–S472. 2 indexed citations

13.

Aksan, A, et al.. (2019). Serum Hepcidin Levels Predict Intestinal Iron Absorption in Patients with Inflammatory Bowel Disease. Clinical Laboratory. 65(03/2019). 12 indexed citations

14.

Stein, Jürgen M., et al.. (2018). Safety and efficacy of intravenous iron isomaltoside for correction of anaemia in patients with inflammatory bowel disease in everyday clinical practice. Scandinavian Journal of Gastroenterology. 53(9). 1059–1065. 14 indexed citations

15.

Dignaß, Axel, K Farrag, & Jürgen M. Stein. (2018). Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. SHILAP Revista de lepidopterología. 2018. 1–11. 186 indexed citations

16.

Berger, C, et al.. (2018). P717 Comparison of two different techniques to assess vedolizumab trough levels in adult patients with IBD. Journal of Crohn s and Colitis. 12(supplement_1). S474–S474. 1 indexed citations

17.

Stein, Jürgen M., A Aksan, K Farrag, Axel Dignaß, & Heinfried H. Radeke. (2017). Management of inflammatory bowel disease-related anemia and iron deficiency with specific reference to the role of intravenous iron in current practice. Expert Opinion on Pharmacotherapy. 18(16). 1721–1737. 23 indexed citations

18.

Rüb, Udo, K Farrag, Kay Seidel, et al.. (2013). Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2). Journal of the Neurological Sciences. 333. e299–e299. 2 indexed citations

19.

Rüb, Udo, K Farrag, Kay Seidel, et al.. (2013). Involvement of the cholinergic basal forebrain nuclei in spinocerebellar ataxia type 2 (SCA2). Neuropathology and Applied Neurobiology. 39(6). 634–643. 15 indexed citations

20.

Rüb, Udo, Katrin Bürk, Dagmar Timmann, et al.. (2012). Spinocerebellar ataxia type 1 (SCA1): new pathoanatomical and clinico‐pathological insights. Neuropathology and Applied Neurobiology. 38(7). 665–680. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact